Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Physiological Effects of FGF21 in Humans and Its Pathophysiological Role in Alcohol Dependence

NCT03892369 is registered in ClinicalTrials.gov with University Hospital, Gentofte, Copenhagen as lead sponsor.

NCT NCT03892369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03892369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Physiological Effects of FGF21 in Humans and Its Pathophysiological Role in Alcohol Dependence
Lead sponsor
University Hospital, Gentofte, Copenhagen
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2019
Completion date
September 1, 2021
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abuse or dependence